Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Net Margin (2016 - 2025)

Utah Medical Products has reported Net Margin over the past 16 years, most recently at 102.08% for Q4 2025.

  • Quarterly results put Net Margin at 102.08% for Q4 2025, down 9559.0% from a year ago — trailing twelve months through Dec 2025 was 1.33% (down 2670.0% YoY), and the annual figure for FY2025 was 1.33%, down 2670.0%.
  • Net Margin for Q4 2025 was 102.08% at Utah Medical Products, down from 26.81% in the prior quarter.
  • Over the last five years, Net Margin for UTMD hit a ceiling of 35.61% in Q3 2024 and a floor of 102.08% in Q4 2025.
  • Median Net Margin over the past 5 years was 30.59% (2022), compared with a mean of 12.71%.
  • Biggest five-year swings in Net Margin: skyrocketed 5437bps in 2024 and later tumbled -9559bps in 2025.
  • Utah Medical Products' Net Margin stood at 20.4% in 2021, then tumbled by -31bps to 26.73% in 2022, then plummeted by -128bps to 60.85% in 2023, then skyrocketed by 89bps to 6.49% in 2024, then plummeted by -1474bps to 102.08% in 2025.
  • The last three reported values for Net Margin were 102.08% (Q4 2025), 26.81% (Q3 2025), and 30.62% (Q2 2025) per Business Quant data.